Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

Oxidative Medicine and Cellular Longevity
Volume 2015, Article ID 125106, 10 pages
http://dx.doi.org/10.1155/2015/125106
Research Article

High-Dose Polymerized Hemoglobin Fails to Alleviate Cardiac Ischemia/Reperfusion Injury due to Induction of Oxidative Damage in Coronary Artery

1Department of Anesthesiology and Translational Neuroscience Center, West China Hospital, Sichuan University, Chengdu 610041, China
2Department of Medicinal Chemistry, School of Pharmacy, Chengdu Medical College, Chengdu 610083, China
3Department of Anesthesiology, Chengdu Military General Hospital, Chengdu 610083, China
4Institute of Blood Transfusion, Chinese Academy of Medical Sciences, Chengdu 610052, China

Received 6 September 2014; Revised 19 December 2014; Accepted 22 December 2014

Academic Editor: Mengzhou Xue

Copyright © 2015 Qian Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. K. de Vries, K. A. Kortekaas, D. Tsikas et al., “Oxidative damage in clinical ischemia/reperfusion injury: a reappraisal,” Antioxidants and Redox Signaling, vol. 19, no. 6, pp. 535–545, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. A. T. Turer and J. A. Hill, “Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy,” The American Journal of Cardiology, vol. 106, no. 3, pp. 360–368, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. A. I. Alayash, “Blood substitutes: why haven't we been more successful?” Trends in Biotechnology, vol. 32, no. 4, pp. 177–185, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Li, D. Zhu, R. Zhou, W. Wu, Q. Li, and J. Liu, “Hboc attenuates intense exercise-induced cardiac dysfunction,” International Journal of Sports Medicine, vol. 33, no. 5, pp. 338–345, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Li, R. Zhou, X. Xiang et al., “Polymerized human placenta hemoglobin given before ischemia protects rat heart from ischemia reperfusion injury,” Artificial Cells, Blood Substitutes, and Biotechnology, vol. 39, no. 6, pp. 392–397, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. I. George, G.-H. Yi, A. R. Schulman et al., “A polymerized bovine hemoglobin oxygen carrier preserves regional myocardial function and reduces infarct size after acute myocardial ischemia,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 291, no. 3, pp. H1126–H1137, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. T. L. Hekkert, G. P. Dubé, E. Regar et al., “Preoxygenated hemoglobin-based oxygen carrier HBOC-201 annihilates myocardial ischemia during brief coronary artery occlusion in pigs,” American Journal of Physiology: Heart and Circulatory Physiology, vol. 298, no. 3, pp. H1103–H1113, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Li, P. Zhang, J. Liu et al., “Protective effects of hemoglobin-based oxygen carrier given to isolated heart during ischemia via attenuation of mitochondrial oxidative damage,” Free Radical Biology & Medicine, vol. 48, no. 8, pp. 1079–1089, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Li, J. Li, J. Liu et al., “Polymerized placenta hemoglobin attenuates ischemia/reperfusion injury and restores the nitroso-redox balance in isolated rat heart,” Free Radical Biology and Medicine, vol. 46, no. 3, pp. 397–405, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Natanson, S. J. Kern, P. Lurie, S. M. Banks, and S. M. Wolfe, “Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis,” JAMA—Journal of the American Medical Association, vol. 299, no. 19, pp. 2304–2312, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Li, R. Yu, H. H. Zhang et al., “A method for purification and viral inactivation of human placenta hemoglobi,” Artificial Cells, Blood Substitutes and Biotechnology, vol. 34, no. 2, pp. 175–188, 2006. View at Publisher · View at Google Scholar
  12. T. Li, W. Wu, Z. You et al., “Alternative use of isoflurane and propofol confers superior cardioprotection than using one of them alone in a dog model of cardiopulmonary bypass,” European Journal of Pharmacology, vol. 677, no. 1–3, pp. 138–146, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. D. C. Fernandes, J. Wosniak Jr., L. A. Pescatore et al., “Analysis of DHE-derived oxidation products by HPLC in the assessment of superoxide production and NADPH oxidase activity in vascular systems,” American Journal of Physiology—Cell Physiology, vol. 292, no. 1, pp. C413–C422, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. C. E. Cooper, R. Silaghi-Dumitrescu, M. Rukengwa, A. I. Alayash, and P. W. Buehler, “Peroxidase activity of hemoglobin towards ascorbate and urate: a synergistic protective strategy against toxicity of Hemoglobin-Based Oxygen Carriers (hboc),” Biochimica et Biophysica Acta—Proteins and Proteomics, vol. 1784, no. 10, pp. 1415–1420, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. C. C. Widmer, C. P. Pereira, P. Gehrig et al., “Hemoglobin can attenuate hydrogen peroxide-induced oxidative stress by acting as an antioxidative peroxidase,” Antioxidants & Redox Signaling, vol. 12, no. 2, pp. 185–198, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. C.-M. Hai, “Systems biology of HBOC-induced vasoconstriction,” Current Drug Discovery Technologies, vol. 9, no. 3, pp. 204–211, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Cabrales and J. M. Friedman, “HBOC vasoactivity: interplay between nitric oxide scavenging and capacity to generate bioactive nitric oxide species,” Antioxidants and Redox Signaling, vol. 18, no. 17, pp. 2284–2297, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. R. M. Winslow, “Current status of blood substitute research: towards a new paradigm,” Journal of Internal Medicine, vol. 253, no. 5, pp. 508–517, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. B. J. Reeder, D. A. Svistunenko, C. E. Cooper, and M. T. Wilson, “The radical and redox chemistry of myoglobin and hemoglobin: from in vitro studies to human pathology,” Antioxidants and Redox Signaling, vol. 6, no. 6, pp. 954–966, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. C. L. Varnado, T. L. Mollan, I. Birukou, B. J. Z. Smith, D. P. Henderson, and J. S. Olson, “Development of recombinant hemoglobin-based oxygen carriers,” Antioxidants & Redox Signaling, vol. 18, no. 17, pp. 2314–2328, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. J. S. Olson, E. W. Foley, C. Rogge, A.-L. Tsai, M. P. Doyle, and D. D. Lemon, “NO scavenging and the hypertensive effect of hemoglobin-based blood substitutes,” Free Radical Biology and Medicine, vol. 36, no. 6, pp. 685–697, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. F. D'Agnillo and T. M. Chang, “Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties,” Nature Biotechnology, vol. 16, no. 7, pp. 667–671, 1998. View at Google Scholar
  23. T. Li, R. Zhou, Y. Yao et al., “Angiotensin-converting enzyme inhibitor captopril reverses the adverse cardiovascular effects of polymerized hemoglobin,” Antioxidants & Redox Signaling, vol. 21, no. 15, pp. 2095–2108, 2014. View at Publisher · View at Google Scholar